WaferGen launches SmartChip Human microRNA Panel V2 for gene expression profiling

WaferGen Biosystems, Inc. (OTC Bulletin Board: WGBS), a leading developer of state-of-the-art genomic analysis systems, today announced the launch of its industry-leading SmartChip Human microRNA Panel V2 for gene expression profiling on the SmartChip Real-Time PCR System.  

The SmartChip Human microRNA Panel V2 is a component of the company's platform technology, the SmartChip System, which specifically analyzes microRNAs (Ribonucleic Acid).  MicroRNAs affect gene regulation and their expression is associated with a number of diseases.  This more comprehensive panel specifically enables profiling of 1200 human microRNAs on a single chip, not possible on other real-time PCR systems.  It enables discovery, validation and screening of biomarkers in a flexible, high-throughput, highly cost-effective manner.

"With this enhanced panel we continue to broaden the applicability of the SmartChip System across a spectrum of research needs, thereby expanding its market potential in the multi-billion dollar genomics analysis market.  Analysts estimate the microRNA market at $150 million and view it as growing exponentially at 20%," said Alnoor Shivji, chairman and CEO, WaferGen. "We believe that the SmartChip Human microRNA Panel V2 offers the most comprehensive and up-to-date survey panel on the market, and is a great addition to our growing list of gene panels."